Valneva SE VALN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:45 PM EDT
28.05quote price arrow up+0.15 (+0.54%)
Volume
2,423
52 week range
24.16 - 31.33

...

Loading . . .
  • Open28.14
  • Day High28.19
  • Day Low28.05
  • Prev Close27.90
  • 52 Week High31.33
  • 52 Week High Date05/18/21
  • 52 Week Low24.16
  • 52 Week Low Date05/27/21

Key Stats

  • Market Cap1,288.48M
  • Shares Out91.64M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open28.14
  • Day High28.19
  • Day Low28.05
  • Prev Close27.90
  • 52 Week High31.33
  • 52 Week High Date05/18/21
  • 52 Week Low24.16
  • 52 Week Low Date05/27/21
  • Market Cap1,288.48M
  • Shares Out91.64M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Valneva SE

There is no recent news for this security.

Profile

MORE
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli...
Franck Grimaud
President
Perry Celentano
Chief Operating Officer
David Lawrence
Chief Financial Officer
Olivier Jankowitsch
Vice President
Jason Golan
Vice President
Manfred Tiefenbacher
Vice President - Finance
Address
Campus Bio-Ouest, 6, Rue Alain Bombard
Saint-herblain
44800
France